A phase I–II trial of intraperitoneal cisplatin and α-lnterferon in patients with persistent epithelial ovarian cancer
- 31 March 1990
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 40 (3) , 237-243
- https://doi.org/10.1016/0090-8258(90)90284-r
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvumAmerican Journal of Obstetrics and Gynecology, 1985
- Cytolytic activity of interferon‐gamma and its synergism with 5‐fluorouracilInternational Journal of Cancer, 1984
- Human leukocyte interferon therapy for advanced ovarian carcinomaAmerican Journal of Clinical Oncology, 1982
- SENSITIVITY OF HUMAN OVARIAN CARCINOMA CELLS TO INTERFERON AND OTHER ANTITUMOR AGENTS AS ASSESSED BY AN IN VITRO SEMI‐SOLID AGAR TECHNIQUE*Annals of the New York Academy of Sciences, 1980